Edition:
United Kingdom

Arbutus Biopharma Q2 Earnings Per Share $0.01


Thursday, 2 Aug 2018 

Aug 2 (Reuters) - Arbutus Biopharma Corp ::ARBUTUS REPORTS 2018 SECOND QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE.Q2 EARNINGS PER SHARE $0.01.Q2 REVENUE $1.2 MILLION VERSUS $1.0 MILLION.Q2 REVENUE VIEW $350,000 -- THOMSON REUTERS I/B/E/S.Q2 EARNINGS PER SHARE VIEW $-0.40 -- THOMSON REUTERS I/B/E/S.PHASE 1A/1B STUDY OF AB-452, A NOVEL AND PROPRIETARY ORAL RNA DESTABILIZER, EXPECTED TO BEGIN IN SECOND HALF OF 2018.ALL ORAL COMBINATION PHASE 2 STUDY OF AB-506 AND AB-452 EXPECTED TO BEGIN BY END OF 2019.PHASE 1A/1B STUDY OF AB-506, A SECOND-GENERATION ORAL CAPSID INHIBITOR, INITIATED. 

Company Quote

1.5
0.0 +0.00%
3:52pm BST